Primary Spine Tumors: Diagnosis and Treatment

Michelle J. Clarke, MD; Ehud Mendel, MD; Frank D. Vrionis, MD, PhD


Cancer Control. 2014;21(2):114-123. 

In This Article

Ongoing Monitoring

Depending on pathology, patients should be followed at variable intervals. Although many benign tumors have a very low incidence of recurrence, certain lesions such as giant cell tumors have an 80% local recurrence rate with intralesional resection.[25] Malignant lesions require ongoing periodic monitoring for local recurrence and periodic restaging for metastatic lesions. Due to the multispecialty team involved in patient care, the coordination of monitoring is valuable.